S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Correvio Pharma

Follow

47

Correvio Pharma

Follow

47

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Taurus69

Free

03/14/21 4:39 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

02/13/21 7:16 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

01/26/21 2:47 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

01/03/21 4:06 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

12/08/20 6:26 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

11/14/20 8:24 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

11/03/20 7:53 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

10/17/20 5:27 AM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

09/24/20 10:41 AM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

08/13/20 5:25 AM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

07/25/20 7:06 PM

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

Taurus69

Free

06/14/20 2:06 PM

$corv $0.4199

powerbattles PremiumMember

PremiumMember

06/04/20 1:47 PM

Re: #1,110: @Taurus69 - $corv $0.4199

CORV stop trading what's up?

Taurus69

Free

06/02/20 3:40 AM

$corv $0.4199

Taurus69

Free

05/23/20 6:09 PM

$corv $0.4165

Taurus69

Free

05/10/20 1:57 PM

$corv $0.3946

Taurus69

Free

05/03/20 4:06 AM

$corv $0.39

frankyahoo PremiumMember

PremiumMember

05/02/20 2:50 PM

$CORV EPS beat estimates. Analysts say HOLD. Short volume up in month of April. Loading some next week.

https://www.marketbeat.com/stocks/NASDAQ/CORV/price-target/

Taurus69

Free

04/25/20 3:19 AM

$corv $.4125

Taurus69

Free

04/20/20 4:45 AM

$corv $.3975

dillonview Free

Free

04/14/20 2:42 PM

Re: #1,100: @Taurus69 - $corv $1 with news

I’d be thrilled to see.42 before May.

Taurus69

Free

04/14/20 4:05 AM

$corv $.3902

Taurus69

Free

04/04/20 5:49 PM

$corv $.3713

Taurus69

Free

04/03/20 2:19 AM

$corv $1 with news

Golden Cross PremiumMember

PremiumMember

04/01/20 6:01 AM

$CORV on the upswing

JDUB

Free

04/01/20 2:08 AM

Re: #1,097: @BDEZ - CORV should go up from here.

Would love to hear your target and why??

BDEZ

PremiumMember

04/01/20 1:46 AM

Re: #1,096: @81vette - purchaser,advanz pharma 6.20pps TSX:ADVZ

CORV should go up from here.

81vette

Free

03/31/20 1:28 PM

Re: #1,047: @Golden Cross - ADVANZ PHARMA to Acquire Correvio

purchaser,advanz pharma 6.20pps TSX:ADVZ

81vette

Free

03/31/20 1:02 PM

CORonaVirus,hmmmm,interesting,did anyone else see that

81vette

Free

03/31/20 12:57 PM

accumulating>could be,good long,better company,debt paid off,shareholders happy,good times ahead for them as stock climbs daily on inked deal

81vette

Free

03/31/20 12:09 PM

their drug,cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess®
could be used to help cv19 patients

81vette

Free

03/31/20 12:00 PM

CORV is not shortable,so cant get shorted into oblivion if it runs up huge

81vette

Free

03/31/20 11:58 AM

reason bought for 76ml>The Company's portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride), for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera®/Mabelio® (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat® (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome. Correvio's pipeline of product candidates includes Trevyent®, a drug device combination that is designed to deliver treprostinil, the world's leading treatment for pulmonary arterial hypertension.
this is coming> Brinavess New Drug was applied for fda approval(wonder if it is cv19 related)

81vette

Free

03/31/20 11:26 AM

trend is up,something is coming,inside peeps know what

81vette

Free

03/31/20 11:21 AM

Index - P/E - EPS (ttm) -0.90 Insider Own 0.80% Shs Outstand 54.93M Perf Week 9.44%
Market Cap 20.44M Forward P/E - EPS next Y -0.45 Insider Trans 0.00% Shs Float 54.20M Perf Month -19.11%
Income -36.70M PEG - EPS next Q -0.12 Inst Own 76.60% Short Float 8.41% Perf Quarter -20.83%
Sales 30.30M P/S 0.67 EPS this Y 29.50% Inst Trans -0.14% Short Ratio 0.63 Perf Half Y -83.39%
Book/sh 0.03 P/B 12.40 EPS next Y 44.30% ROA -60.90% Target Price 1.08 Perf Year -87.64%
Cash/sh 0.32 P/C 1.15 EPS next 5Y 28.00% ROE - 52W Range 0.21 - 3.22 Perf YTD -9.24%
Dividend - P/FCF - EPS past 5Y -26.80% ROI -16.30% 52W High -88.35% Beta 0.10
Dividend % - Quick Ratio 1.30 Sales past 5Y 44.80% Gross Margin 70.80% 52W Low 78.67% ATR 0.07
Employees 173 Current Ratio 1.50 Sales Q/Q -4.30% Oper. Margin -90.20% RSI (14) 52.14 Volatility 9.42% 15.81%
Optionable Yes Debt/Eq 29.33 EPS Q/Q -13.30% Profit Margin - Rel Volume 0.53 Prev Close 0.37
Shortable No LT Debt/Eq 22.07 Earnings Apr 08 BMO Payout - Avg Volume 7.22M Price 0.38
Recom 3.00 SMA20 0.85% SMA50 6.24% SMA200 -73.56% Volume 1,017,097 Change 0.84%

81vette

Free

03/31/20 11:17 AM

CORVette is a bolie rider,lots of run room,wiff of cv and boom!!

81vette

Free

03/31/20 11:14 AM

price crossed above 20 day sma,I am in,turn my 10k into 20k,thanks in advance wink

Taurus69

Free

03/28/20 4:52 PM

$corv $.355

JDUB

Free

03/25/20 5:22 PM

Chart looks really good. Still don't understand why it has been trading so far away from the .42 buyout price. Looking for maybe a second offer to come in. Maybe that's why accumulation picked up today on some extra volume.

JDUB

Free

03/24/20 12:59 PM

Re: #1,083: @ezyE - Why wouldn't it ?

They have just been bought for .42 per share.

ezyE

Free

03/24/20 12:51 PM

Re: #1,082: @JDUB - Just exactly why would it go past .42?

Why wouldn't it ?

JDUB

Free

03/23/20 5:57 PM

Re: #1,081: @CyrusDaVirus - You guys know a .38 break will send

Just exactly why would it go past .42?

CyrusDaVirus Free

Free

03/23/20 5:06 PM

You guys know a .38 break will send this crazy thing to blue skies right?

JDUB

Free

03/23/20 3:31 PM

CORV Green now! That came out of nowhere. Still undervalued.

SurgeGuy2.0 Free

Free

03/23/20 12:24 PM

Re: #1,066: @bUrRpPPP! - I just sold CXRXF for $15 from $5.25

Wow, another CRASH and BURN!!!!!! Whoopsie!!!!!!

StockItOut Free

Free

03/22/20 2:41 PM

Re: #1,027: @SurgeGuy2.0 - Wow, another Bloody RED DAY here......looks like the

We see this all the time with Surge Holdings. Similar to Corevvio?

StockItOut Free

Free

03/22/20 2:36 PM

Re: #1,073: @SurgeGuy2.0 - That is complete Bullshit

Spoken like a complete expert on bullshit. Thanks!

SurgeGuy2.0 Free

Free

03/22/20 12:31 PM

Re: #1,066: @bUrRpPPP! - I just sold CXRXF for $15 from $5.25

More Bullshit?

Golden Cross PremiumMember

PremiumMember

03/20/20 6:22 PM

Re: #1,069: @TheGuy87 - Did you see what cxrxf just did omg

The time is hear we believe $CORV

SurgeGuy2.0 Free

Free

03/20/20 10:45 AM

Re: #1,066: @bUrRpPPP! - I just sold CXRXF for $15 from $5.25

I love how some folks lie to make themselves feel better about themselves....kind of sad really.

Older

Correvio Pharma (CORV)

Followers	47	Posters	199
Posts (Today)	0	Posts (Total)	1123
Created	12/20/04	Type	Free
Moderators

Market cap $95 M-- Cash $28 M -- ADCOM meeting likely in November / Potential Blockbuster Drug / 4 Marketed Drugs =STRONG BUY , very attractive stock with brutally upside potential .GL

Correvio Pharma (CORV)

Market Cap $95 Million
Cash $28 Million
Price $1.93

presentation
https://correvio.com/wp-content/uploads/2019/09/Correvio-Corp-Presentation-Sep-2019.pdf

Resubmission accepted by FDA in July 2019
FDA Advisory Committee expected Q4 2019
PDUFA date of December 24, 2019

Brinavess -NDA-stage acute care product, with a potential ~$500M US dollar market opportunity,~20% penetration of total US atrial fibrillation patient population..

https://thefly.com/landingPageNews.php?id=2957573

Correvio initiated with an Overweight at Cantor Fitzgerald Cantor Fitzgerald analyst Louise Chen started Correvio with an Overweight rating and $6 price target. Upward earnings revisions for the company's commercial products and pipeline should drive the shares higher, Chen tells investors in a research note. The analyst is expecting approval of Brinavess in late December, and believes the drug could be Correvio's first blockbuster opportunity.

Volume:
Day Range:
Last Trade Time:

Delayed by 15 minutes

1D
1M
3M
6M
1Y
5Y

CORV Latest News

No Recent News Available for this company!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow